Pharmacology is the study of how chemical substances interact with living systems. To develop a drug, one needs to understand the underlying pharmacokinetics and pharmacodynamics to effectively guide the chemistry. Our expert, Dr. Terry Kenakin with GSK, will provide insights into how pharmacology can help guide your structure-activity relationships in discovery chemistry, and what assays can (and can’t) tell you. Don’t miss out on the opportunity for an in-depth Q&A session, join us LIVE!
“Know Your Drugs – A Pharmacology Primer for Chemical and Life Science Professionals” A short presentation followed by Q&A with speaker Terry Kenakin , Director of GlaxoSmithKline Research and Development.
What You Will Learn
- The overview of the modern drug discovery process
- How pharmacokinetics and pharmacodynamics are utilized to guide the three major structure-activity relationships in discovery: primary target efficacy, PK and ADME properties and safety
- The primary assays used in discovery and development to guide optimization of efficacy and PK properties; what these assays give you and how to interpret the data
- And much more…
Date: Thursday, March 24, 2011
Time: 2:00-3:00 pm ET
Meet Your Expert
Terry Kenakin is a director at GlaxoSmithKline Research and Development in North Carolina. Terry obtained his B.S. in Chemistry and Ph.D. in Pharmacology at the University of Alberta, Canada. After three years at University College, London, UK, he joined Burroughs-Wellcome as a Senior Research Pharmacologist. He then went on to join GlaxoSmithKline where he excelled professionally. He has applied his expertise by authoring eight books on Pharmacology including most recently A Pharmacology Primer, Third Edition: Theory, Application and Methods. Additionally, he serves as Co-Editor-in-Chief of the International Journal of Receptors and Signal Transduction and Current Opinion in Pharmacology.
Meet the Moderator
Dr. Ann Newman is a pharmaceutical consultant at Seventh Street Development Group, a consulting and training firm specializing in solid state chemistry and pharmaceutical development. She has over 20 years of large pharma and contract research experience. She holds an adjunct faculty position in Industrial and Physical Pharmacy at Purdue Univ. and is an author/collaborator on over 100 articles, book chapters, and scientific presentations. Dr. Newman received her PhD in chemistry from the Univ. of Connecticut.
This episode of ACS Webinars™ is co-produced with ACS Professional Education. Learn more at http://www.proed.acs.org/.
The Fine Print
ACS Webinars™ does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.